Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. provides medical devices and solutions in China and internationally. The company offers various products, including patient monitoring, ultrasound, radiology, AED, defibrillation system, anesthesia, CLIA, chemistry, hematology, ventilators, electrocardiograph, endoscope camera system, operating tables, surgical lights, medical supply units, acces… Read more
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (300760) - Total Assets
Latest total assets as of September 2025: CN¥59.27 Billion CNY
Based on the latest financial reports, Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (300760) holds total assets worth CN¥59.27 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A - Total Assets Trend (2014–2024)
This chart illustrates how Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A - Asset Composition Analysis
Current Asset Composition (December 2024)
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's total assets of CN¥59.27 Billion consist of 45.3% current assets and 54.7% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 29.4% |
| Accounts Receivable | CN¥3.43 Billion | 6.1% |
| Inventory | CN¥4.76 Billion | 8.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥7.08 Billion | 12.5% |
| Goodwill | CN¥11.09 Billion | 19.6% |
Asset Composition Trend (2014–2024)
This chart illustrates how Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's current assets represent 45.3% of total assets in 2024, a decrease from 63.7% in 2014.
- Cash Position: Cash and equivalents constituted 29.4% of total assets in 2024, up from 12.2% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 31.0% of total assets, an increase from 16.0% in 2014.
- Asset Diversification: The largest asset category is goodwill at 19.6% of total assets.
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A Competitors by Total Assets
Key competitors of Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A generates 0.65x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A generates $ 20.60 in net profit.
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.54 | 2.34 | 2.63 |
| Quick Ratio | 2.07 | 1.92 | 2.20 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥16.74 Billion | CN¥ 15.54 Billion | CN¥ 13.40 Billion |
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A - Advanced Valuation Insights
This section examines the relationship between Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.73 |
| Latest Market Cap to Assets Ratio | 0.22 |
| Asset Growth Rate (YoY) | 18.2% |
| Total Assets | CN¥56.64 Billion |
| Market Capitalization | $12.61 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's assets below their book value (0.22 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's assets grew by 18.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (2014–2024)
The table below shows the annual total assets of Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥56.64 Billion | +18.16% |
| 2023-12-31 | CN¥47.94 Billion | +2.56% |
| 2022-12-31 | CN¥46.75 Billion | +22.68% |
| 2021-12-31 | CN¥38.10 Billion | +14.40% |
| 2020-12-31 | CN¥33.31 Billion | +29.93% |
| 2019-12-31 | CN¥25.63 Billion | +18.53% |
| 2018-12-31 | CN¥21.63 Billion | +49.79% |
| 2017-12-31 | CN¥14.44 Billion | +11.29% |
| 2016-12-31 | CN¥12.97 Billion | +4.94% |
| 2015-12-31 | CN¥12.36 Billion | -15.21% |
| 2014-12-31 | CN¥14.58 Billion | -- |